Skip to content

The effects of beta-blocker on the hypertension in chronic kidney disease

The effects of beta-blocker on the hypertension in chronic kidney disease - beta-blocker in CKD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000021062
Enrollment
30
Registered
2016-02-16
Start date
2014-07-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic kidney disease

Interventions

beta-blocker diuretics

Sponsors

Shu Wakino
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: hypertensive patients with CKD

Exclusion criteria

Exclusion criteria: asthma bradycardia AV block heart failure

Design outcomes

Primary

MeasureTime frame
renal function, glucose metabolism, and cardiac function

Secondary

MeasureTime frame
inflammation, oxidative stress level

Countries

Japan

Contacts

Public ContactShu Wakino

Keio University Department of Medicine

shuwakino@z8.keio.jp03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026